AbbVie invests $380 million to build two new API manufacturing facilities in North Chicago while Bora Pharmaceuticals Co., Ltd. and GSK have renewed a five-year global manufacturing partnership.

Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.

The Chicago-based biopharmaceutical company AbbVie made a significant move on Feb. 23, as part of its broader commitment to ...

AbbVie is investing $380 million to build two new active pharmaceutical ingredient manufacturing facilities at its headquarters campus in North Chicago. Construction is set to begin in spring 2026, ...

Just like algae blooms in the ocean and pollen in the spring, there’s been an explosion in the past year or two of new software, related tools and lingo from the IT and mainstream/consumer side. Some ...

The Align Foundation, a nonprofit accelerating predictive biology by convening the world's leading minds to generate and optimize the data that powers AI breakthroughs, today announced a partnership ...

Microsize brings over thirty years of expertise in specialized particle size engineering for the pharmaceutical ...

Foundational Technology Developed and Contracted from Georgia Institute of Technology [PLN] is expected to enhance both ...

WILMINGTON, DE - February 24, 2026 - PRESSADVANTAGE - The digital world is currently navigating a "Verification ...

Share Market Live Updates - Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 25th February 2026.

FORT COLLINS, CO - February 24, 2026 - PRESSADVANTAGE - Mold Removal Express, a family-operated mold remediation ...